Abnormal right ventricular echocardiographic findings in recovered patients associated with severe acute respiratory syndrome in COVID‐19

Background Right ventricular (RV) echocardiographic changes such as dilation or systolic dysfunction, and pulmonary arterial hypertension were observed in patients with COVID‐19. The aim of our study was to determine the frequency of RV echocardiographic changes in patients who have recovered from COVID‐19 and to verify the association between severe acute respiratory syndrome (SARS) and echocardiographic findings. Methods Patients who had recovered from COVID‐19 undergoing outpatient follow‐up underwent transthoracic echocardiography, and based on the findings, were divided into two groups: normal and abnormal. It was then verified whether there is an association between SARS and RV echocardiographic abnormalities in recovered patients. Results The study included 61 patients, with a mean age of 54.2 ± 12.0 years, 57.4% had presented with SARS. The mean period of time between COVID‐19 and the echocardiographic examination was 11.9 ± 7.0 months. Patients presented normal left ventricular systolic function. The frequency of RV echocardiographic changes in patients who had recovered from COVID‐19 was 44.3%. RV systolic dysfunction was identified in 31.1%, followed by ventricular dilation in 14.7% and pulmonary hypertension in 9.8%. An association was observed between SARS and RV echocardiographic changes in recovered patients during outpatient follow‐up (OR: 4.96; 95% CI: 1.37–17.9; p = 0.015). An association was also demonstrated between SARS and RV dilation (p = 0.007) and between SARS and systolic dysfunction (p = 0.028). Conclusion SARS is a risk factor for abnormal RV echocardiographic findings in patients recovered from COVID‐19.